Barclays sets Brookfield Renewable stock at Equalweight, $31 target

Published 03/04/2025, 11:42
Barclays sets Brookfield Renewable stock at Equalweight, $31 target

On Thursday, Barclays (LON:BARC) initiated coverage on Brookfield Renewable Corp . (NYSE:BEPC) with an Equalweight rating and a price target of $31.00, aligning with InvestingPro data showing analyst targets ranging from $31 to $36. The new coverage comes amid observations of the company’s $9.66 billion market cap and its relationship with Brookfield Renewable Partners L.P. (NYSE:BEP).

Brookfield Renewable Corp. shares, structured to be economically equivalent to BEP LP units, offer identical dividends and distributions, with InvestingPro data showing a significant 5.24% dividend yield and a 5-year consecutive dividend growth streak. Shareholders have the flexibility to exchange BEPC exchangeable shares for BEP LP units at any time. Notably, BEPC shares have historically traded at a premium compared to BEP shares, a trend attributed to investor preference for corporate structures that issue 1099 tax forms over partnership structures that issue K-1 forms.

Throughout most of 2023 and the beginning of 2024, this premium remained in the mid to high single digits. However, it escalated to double digits in early May 2024, coinciding with increasing investor interest in AI and data center demand. This period also saw BEP sign a significant 10.5 GW framework agreement with Microsoft (NASDAQ:MSFT).

While Barclays acknowledges that a small premium might be justified due to the tax reporting differences between BEPC and BEP, the current wide premium raises questions. The firm anticipates that the premium will eventually revert closer to the average, leading to a narrowing of the valuation gap between BEPC shares and BEP units over time. The analysis suggests a cautious approach to the stock’s current valuation, with InvestingPro data showing a P/E ratio of 40.5x and indicating the stock is currently trading near its Fair Value. The company maintains a FAIR overall financial health score, though investors should note that analysts expect net income to decline this year.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.